Masayuki Yokode

9.6k total citations · 1 hit paper
141 papers, 5.8k citations indexed

About

Masayuki Yokode is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Masayuki Yokode has authored 141 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 35 papers in Molecular Biology and 25 papers in Epidemiology. Recurrent topics in Masayuki Yokode's work include Lipoproteins and Cardiovascular Health (23 papers), Adipokines, Inflammation, and Metabolic Diseases (19 papers) and Atherosclerosis and Cardiovascular Diseases (17 papers). Masayuki Yokode is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Adipokines, Inflammation, and Metabolic Diseases (19 papers) and Atherosclerosis and Cardiovascular Diseases (17 papers). Masayuki Yokode collaborates with scholars based in Japan, Russia and United States. Masayuki Yokode's co-authors include Toshinori Murayama, Toru Kita, Hidenori Arai, Hideto Sano, Tamio Teramoto, Kazuhiko Hirobe, Hiroyuki Daida, Genshi Egusa, Junichi Sasaki and Makoto Kinoshita and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Masayuki Yokode

138 papers receiving 5.7k citations

Hit Papers

Executive Summary of the Japan Atherosclerosis Society (J... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
    2013 378 citations Tamio Teramoto, Junichi Sasaki et al. Journal of Atherosclerosis and Thrombosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Yokode Japan 41 1.6k 1.5k 876 843 832 141 5.8k
Juan Antonio Moreno Spain 44 1.9k 1.2× 1.1k 0.7× 550 0.6× 769 0.9× 628 0.8× 167 6.2k
Domenico Girelli Italy 59 2.2k 1.3× 1.1k 0.8× 855 1.0× 454 0.5× 790 0.9× 288 12.7k
Po‐Hsun Huang Taiwan 44 2.1k 1.3× 1.2k 0.8× 1.6k 1.8× 636 0.8× 753 0.9× 248 6.5k
Zuyi Yuan China 37 1.7k 1.0× 968 0.7× 1.4k 1.6× 474 0.6× 665 0.8× 240 5.3k
Massimiliano Ruscica Italy 49 1.7k 1.1× 2.5k 1.7× 894 1.0× 943 1.1× 1.3k 1.5× 226 7.0k
Xiangmei Chen China 52 3.3k 2.0× 1.3k 0.9× 720 0.8× 623 0.7× 1.1k 1.3× 578 10.8k
Carlo Sabbà Italy 46 1.5k 0.9× 1.7k 1.2× 625 0.7× 490 0.6× 1.3k 1.5× 211 6.7k
Christoph Meier Switzerland 45 1.3k 0.8× 703 0.5× 605 0.7× 412 0.5× 665 0.8× 94 5.3k
Hwee Teoh Canada 39 1.8k 1.1× 1.3k 0.9× 1.9k 2.2× 501 0.6× 894 1.1× 151 5.9k
Hubert Scharnagl Austria 49 1.4k 0.9× 2.6k 1.8× 1.6k 1.9× 794 0.9× 1.3k 1.5× 265 7.4k

Countries citing papers authored by Masayuki Yokode

Since Specialization
Citations

This map shows the geographic impact of Masayuki Yokode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Yokode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Yokode more than expected).

Fields of papers citing papers by Masayuki Yokode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Yokode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Yokode. The network helps show where Masayuki Yokode may publish in the future.

Co-authorship network of co-authors of Masayuki Yokode

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Yokode. A scholar is included among the top collaborators of Masayuki Yokode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Yokode. Masayuki Yokode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagata, Manabu, Manabu Minami, Kazumichi Yoshida, et al.. (2020). Calcium‐Binding Protein S100A4 Is Upregulated in Carotid Atherosclerotic Plaques and Contributes to Expansive Remodeling. Journal of the American Heart Association. 9(18). e016128–e016128. 11 indexed citations
2.
Yokode, Masayuki, et al.. (2020). EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes. Diabetes and Vascular Disease Research. 17(4). 3154007051–3154007051. 16 indexed citations
3.
Miyata, Takeshi, Manabu Minami, Hiroharu Kataoka, et al.. (2020). Osteoprotegerin Prevents Intracranial Aneurysm Progression by Promoting Collagen Biosynthesis and Vascular Smooth Muscle Cell Proliferation. Journal of the American Heart Association. 9(17). e015731–e015731. 13 indexed citations
4.
Higuchi, Sei, Taichi Ikedo, Manabu Nagata, et al.. (2018). EP4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice. American Journal of Physiology-Endocrinology and Metabolism. 316(3). E410–E417. 2 indexed citations
5.
Ikedo, Taichi, Manabu Minami, Hiroharu Kataoka, et al.. (2017). Imaging mass spectroscopy delineates the thinned and thickened walls of intracranial aneurysms. Biochemical and Biophysical Research Communications. 495(1). 332–338. 10 indexed citations
6.
Higuchi, Sei, Taichi Ikedo, Manabu Nagata, et al.. (2017). Behavioral abnormalities and reduced norepinephrine in EP4 receptor-associated protein (EPRAP)-deficient mice. Biochemical and Biophysical Research Communications. 486(2). 584–588. 3 indexed citations
7.
Higuchi, Sei, Taichi Ikedo, Manabu Nagata, et al.. (2017). Deficiency in EP4 Receptor–Associated Protein Ameliorates Abnormal Anxiety-Like Behavior and Brain Inflammation in a Mouse Model of Alzheimer Disease. American Journal Of Pathology. 187(8). 1848–1854. 5 indexed citations
8.
Minakata, Kenji, Atsushi Kawaguchi, Takafumi Ikeda, et al.. (2016). Transcutaneous oxygen pressure as a surrogate index of lower limb amputation.. PubMed. 35(6). 565–572. 13 indexed citations
9.
Higuchi, Sei, Taichi Ikedo, Kosuke Hayashi, et al.. (2016). EP4 Receptor–Associated Protein in Macrophages Protects against Bleomycin-Induced Pulmonary Inflammation in Mice. The Journal of Immunology. 197(11). 4436–4443. 7 indexed citations
10.
Yamamoto, Keiichi, Eriko Sumi, Tōru Yamazaki, et al.. (2012). A pragmatic method for electronic medical record-based observational studies: developing an electronic medical records retrieval system for clinical research. BMJ Open. 2(6). e001622–e001622. 16 indexed citations
11.
Morimoto, Naoki, Tatsuya Ito, Satoru Takemoto, et al.. (2012). An exploratory clinical study on the safety and efficacy of an autologous fibroblast‐seeded artificial skin cultured with animal product‐free medium in patients with diabetic foot ulcers. International Wound Journal. 11(2). 183–189. 22 indexed citations
12.
Sumi, Eriko, Toshinori Murayama, Masafumi Kitakaze, et al.. (2011). A Multi-institutional Descriptive Study on the Methods of Subject Recruitment for Clinical Trials. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 42(1). 27–31.
13.
Murayama, Toshinori, et al.. (2011). Trend Analysis of Research on Informed Consent in Clinical Trials: Comprehensive Retrieval via Electronic Databases. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 42(1). 21–25. 1 indexed citations
14.
Yanagihara, Kazuhiro, et al.. (2011). Developing the Questionnaire of Achievement Motive for Medical Treatment. 51(1). 73–79. 1 indexed citations
15.
Wada, Hiromichi, Noriko Satoh‐Asahara, Takahiro Horie, et al.. (2011). Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects. PLoS ONE. 6(12). e29351–e29351. 49 indexed citations
16.
Sugimoto, Masayuki, Hidenori Arai, Yukinori Tamura, et al.. (2008). Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice. Atherosclerosis. 204(2). 388–394. 51 indexed citations
17.
Teramoto, Tamio, Jun Sasaki, Hirotsugu Ueshima, et al.. (2007). 異脂肪血症の診断基準-日本人のためのアテローム硬化型心血管疾患の診断ならびに予防に関する日本アテローム性動脈硬化症学会(JAS)ガイドラインの要点. Journal of Atherosclerosis and Thrombosis. 14(4). 155–158. 1 indexed citations
18.
Teramoto, Tamio, Junichi Sasaki, Hirotsugu Ueshima, et al.. (2007). Diagnostic Criteria for Dyslipidemia - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese:— Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese. Journal of Atherosclerosis and Thrombosis. 14(4). 155–158. 9 indexed citations
19.
Teramoto, Tamio, Junichi Sasaki, Hirotsugu Ueshima, et al.. (2007). Risk Factors of Atherosclerotic Diseases - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese. Journal of Atherosclerosis and Thrombosis. 14(6). 267–277. 46 indexed citations
20.
Kume, Noriaki, Masayuki Yokode, Kenji Ishii, et al.. (2000). Oxidized‐LDL and Atherosclerosis: Role of LOX‐1. Annals of the New York Academy of Sciences. 902(1). 95–102. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Antonio Moreno Breakdown of academic impact, for papers by Domenico Girelli Breakdown of academic impact, for papers by Po‐Hsun Huang Breakdown of academic impact, for papers by Zuyi Yuan Breakdown of academic impact, for papers by Massimiliano Ruscica Breakdown of academic impact, for papers by Xiangmei Chen Breakdown of academic impact, for papers by Carlo Sabbà Breakdown of academic impact, for papers by Christoph Meier Breakdown of academic impact, for papers by Hwee Teoh Breakdown of academic impact, for papers by Hubert Scharnagl
Rankless by CCL
2026